Meyer, Alexa R.
Carducci, Michael A.
Denmeade, Samuel R.
Markowski, Mark C.
Pomper, Martin G.
Pierorazio, Philip M.
Allaf, Mohamad E.
Rowe, Steven P.
Gorin, Michael A.
Article History
Received: 24 March 2019
Accepted: 21 May 2019
First Online: 30 May 2019
Compliance with ethical standards
:
: MGP is a co-inventor on a US Patent covering <sup>18</sup>F-DCFPyL and as such is entitled to a portion of any licensing fees and royalties generated by this technology. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. MAG has served as a consultant to Progenics Pharmaceuticals, the licensee of <sup>18</sup>F-DCFPyL. SPR, MAG, and MGP have received research support from Progenics Pharmaceuticals.